ImClone Systems, LLC
IN, United States
CMS manufacturer 100000000063
General payments
$1,750,982
Research payments
$138,029
Ownership & investment interest
$0
Through program year 2024, ImClone Systems, LLC reported paying $1,750,982 in general payments and $138,029 in research payments to U.S. physicians, teaching hospitals and other recipients.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $441,833 | 12 |
| 2024 | Research | $34,567 | 1 |
| 2023 | General | $414,599 | 13 |
| 2022 | General | $243,650 | 7 |
| 2022 | Research | $5,560 | 1 |
| 2021 | General | $272,623 | 9 |
| 2021 | Research | $17,341 | 2 |
| 2020 | General | $205,920 | 8 |
| 2020 | Research | $59,502 | 3 |
| 2019 | General | $172,359 | 10 |
| 2019 | Research | $21,059 | 5 |
Breakdown
Each share is of this company’s general payments in 2024 where a state was reported.
Records
59 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.